Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 116 | 966 | 634 | 1,415 | 1,319 |
| Receivables | 135 | 56 | 217 | 134 | 93 |
| Inventories | 64 | 26 | N/A | N/A | N/A |
| Other current assets | 29 | 110 | 36 | 17 | 16 |
| TOTAL | $344 | $1,158 | $887 | $1,566 | $1,429 |
| Non-Current Assets | |||||
| PPE Net | 40 | 39 | 42 | 43 | 36 |
| Intangibles | 789 | 793 | 954 | 915 | 1,005 |
| TOTAL | $829 | $831 | $996 | $958 | $1,042 |
| Total Assets | $1,173 | $1,989 | $1,884 | $2,525 | $2,471 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 449 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 111 | 93 | N/A | N/A | N/A |
| TOTAL | $254 | $665 | $187 | $177 | $93 |
| Non-Current Liabilities | |||||
| Long Term Debt | 439 | N/A | 413 | N/A | N/A |
| TOTAL | $439 | $0 | $413 | $0 | $0 |
| Total Liabilities | $693 | $665 | $600 | $177 | $93 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 0 | 0 | 8,506 |
| Retained earnings | -14,718 | -13,008 | -11,393 | -9,946 | -8,486 |
| Other shareholders' equity | 185 | 306 | 507 | 1,124 | 828 |
| TOTAL | $480 | $1,325 | $1,283 | $2,348 | $2,378 |
| Total Liabilities And Equity | $1,173 | $1,989 | $1,884 | $2,525 | $2,471 |